Astellas Pharma Inc (OTCPK:ALPMY)
$ 13.73 -0.69 (-4.79%) Market Cap: 24.60 Bil Enterprise Value: 26.29 Bil PE Ratio: 12.80 PB Ratio: 2.21 GF Score: 81/100

Q2 2021 Astellas Pharma Inc Earnings Presentation Transcript

Oct 30, 2020 / NTS GMT
Release Date Price: $13.73 (-1.29%)

Oct 30, 2020 / NTS GMT
Presentation
Oct 30, 2020 / NTS GMT

=====================
Corporate Participants
=====================
* Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Representative Director
* Mike Kitagawa
Astellas Pharma Inc. - Senior VP of Development Project Management
* Naoki Okamura
Astellas Pharma Inc. - Executive VP, CFO & Representative Director
* Yukio Matsui
Astellas Pharma Inc. - Chief Commercial Officer & Senior Corporate Executive

=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
* Yo Mizuno
Tokio Marine Asset

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot